BenzingaAugust 11, 2026 at 12:39 PM NY24 days ago

BridgeBio Oncology Q2 EPS $(705.20) Misses $(0.57) Estimate

BridgeBio Oncology (NASDAQ:BBOT) reported quarterly losses of $(705.20) per share which missed the analyst consensus estimate of $(0.57) by 123619.3 percent. This is a 24.49 percent decrease over losses of $(566.46) per

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Benzinga

Read at Source

Companies in This Story

BBOTBridgeBio Oncology Therapeutics Inc8.98+ 0.90%

Companies in This Story

Related Stories